COVID-19診断薬の市場規模、シェア、成長分析：製品別、サンプルタイプ別、検査タイプ別、モード別、最終用途別、地域別 - 産業予測 2025～2032年

COVID-19診断薬市場規模は2023年に320億3,000万米ドルと評価され、2024年の385億米ドルから2032年には1,677億6,000万米ドルに成長し、予測期間中（2025年～2032年）にCAGR 20.2％で成長する見通しです。

COVID-19パンデミックは、2019年12月に中国の武漢で発生し、その後世界中で60億人以上の死者を出すに至り、世界の健康と経済に深刻な影響を与えました。ウイルスの急速な拡大により、世界保健機関は2020年3月にパンデミック宣言を行った。医療システムは圧倒されており、診断と治療法の緊急な進歩が必要とされています。同時に、封鎖措置が経済的困難を悪化させ、失業率の上昇とインフレが世界のGDP減少の一因となっています。研究努力は、特に免疫療法、抗ウイルス剤、細胞ベースの治療において、205の可能性のある治療法と124のワクチンに集中しています。主な研究分野には、抗体開発やRNAベースのワクチンなどがあり、効果的な解決策を導き出し、公衆衛生の回復力を確保するためには、ウイルスに関する包括的なデータが不可欠であることを強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

COVID-19診断薬市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 機器
• 試薬とキット
• サービス

COVID-19診断薬市場規模：サンプルタイプ別& CAGR（2025-2032）

• 市場概要
• 鼻咽頭スワブ（NP）
• 口腔咽頭スワブ
• 鼻腔スワブ
• 血
• その他

COVID-19診断薬市場規模：検査タイプ別& CAGR（2025-2032）

• 市場概要
• 分子（PCR）検査
• 抗原検査
• 抗体（血清学）検査
• その他

COVID-19診断薬市場規模：モード別& CAGR（2025-2032）

• 市場概要
• ポイントオブケア（PoC）
• 非ポイントオブケア（非PoC）

COVID-19診断薬市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 研究所
• 病院
• 診断センターとクリニック
• その他

COVID-19診断薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific（United States）
• Hologic, Inc.（United States）
• QuidelOrtho Corporation（United States）
• QIAGEN N.V.（Netherlands）
• bioMerieux（France）
• Laboratory Corporation of America Holdings（Labcorp）（United States）
• Abbott Laboratories（United States）
• F. Hoffmann-La Roche AG（Switzerland）
• Siemens Healthineers AG（Germany）
• Becton, Dickinson and Company（BD）（United States）
• PerkinElmer, Inc.（United States）
• Danaher Corporation（United States）
• Bio-Rad Laboratories, Inc.（United States）
• OraSure Technologies, Inc.（United States）
• Luminex Corporation（United States）
• Seegene Inc.（South Korea）
• Tecan Group Ltd.（Switzerland）

結論と推奨事項

COVID-19 Diagnostics Market size was valued at USD 32.03 billion in 2023 and is poised to grow from USD 38.5 billion in 2024 to USD 167.76 billion by 2032, growing at a CAGR of 20.2% during the forecast period (2025-2032).

The COVID-19 pandemic has profoundly affected global health and economies, originating in Wuhan, China, in December 2019 and subsequently leading to over 6 billion deaths worldwide. The rapid spread of the virus prompted the World Health Organization to declare it a pandemic in March 2020. Health systems are overwhelmed, necessitating urgent advancements in diagnosis and treatment options. Concurrently, lockdown measures have exacerbated economic difficulties, with rising unemployment and inflation contributing to global GDP decline. Research efforts are focused on 205 potential therapies and 124 vaccines, particularly in immunotherapy, antivirals, and cell-based treatments. Key areas of investigation include antibody development and RNA-based vaccines, highlighting the critical need for comprehensive data on the virus to inform effective solutions and ensure public health resilience.

Top-down and bottom-up approaches were used to estimate and validate the size of the Covid-19 Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Covid-19 Diagnostics Market Segments Analysis

Global COVID-19 Diagnostics Market is segmented by Product, Sample Type, Test Type, Mode, End-use and region. Based on Product, the market is segmented into Instruments, Reagents & Kits and Services. Based on Sample Type, the market is segmented into Nasopharyngeal (NP)swabs, Oropharyngeal (OP) swabs, Nasal swabs, Blood and Others. Based on Test Type, the market is segmented into Molecular (PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing and Others. Based on Mode, the market is segmented into Point-of-Care (PoC) and Non-Point-of-Care (Non-PoC). Based on End-use, the market is segmented into Laboratories, Hospitals, Diagnostic Centers and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Covid-19 Diagnostics Market

The COVID-19 diagnostics market has experienced significant growth due to the global response to the pandemic, as governments implemented lockdowns and invested heavily in healthcare and life sciences. This support catalyzed the rapid development of diagnostic tests and treatments for the virus. Furthermore, the FDA introduced an emergency use authorization (EUA) pathway, allowing for the swift approval of various therapies aimed at combatting COVID-19. Consequently, numerous pharmaceutical, biotechnology, and biopharmaceutical companies received EUA approvals, facilitating ongoing clinical studies and bolstering innovation in diagnostics. These concerted efforts have been pivotal in addressing the health crisis and enhancing diagnostic capabilities worldwide.

Restraints in the Covid-19 Diagnostics Market

One significant obstacle hindering the progress of the Covid-19 diagnostics market is the insufficient information regarding the novel coronavirus, particularly its biological and genetic characteristics, as well as the longevity of immunity in individuals who have recovered from the virus. This knowledge is crucial for the creation of safe and effective diagnostic solutions. Furthermore, as the industry moves forward, it must navigate challenges related to production capacity and distribution logistics. Consequently, alongside ongoing vaccine development, manufacturers are prioritizing the enhancement of their production capabilities to address these emerging challenges effectively.

Market Trends of the Covid-19 Diagnostics Market

The Covid-19 diagnostics market has exhibited a significant shift towards in vitro diagnostics, with a strong emphasis on developing highly reliable and cost-effective testing solutions. As of July 2021, over 500 point-of-care (POC) diagnostic tests were available, reflecting a growing trend towards rapid testing that delivers faster results to facilitate timely decision-making. This surge in innovation is driven by collaboration between private companies and government initiatives to enhance public health response capabilities. The focus on improving test accuracy and accessibility underscores a market trajectory toward more sophisticated diagnostic technologies, which are anticipated to shape ongoing pandemic management and preparedness for future outbreaks.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global COVID-19 Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits
• Services

Global COVID-19 Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Nasopharyngeal (NP) swabs
• Oropharyngeal (OP) swabs
• Nasal swabs
• Blood
• Others

Global COVID-19 Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Molecular (PCR) Testing
• Antigen-based Testing
• Antibody (Serology) Testing
• Others

Global COVID-19 Diagnostics Market Size by Mode & CAGR (2025-2032)

• Market Overview
• Point-of-Care (PoC)
• Non-Point-of-Care (Non-PoC)

Global COVID-19 Diagnostics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Laboratories
• Hospitals
• Diagnostic Centers and Clinics
• Others

Global COVID-19 Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Sample Type, Test Type, Mode, End-use)
  • US
  • Canada
• Europe (Product & Service, Sample Type, Test Type, Mode, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Sample Type, Test Type, Mode, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Sample Type, Test Type, Mode, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Sample Type, Test Type, Mode, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations